Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBM Practice Standards May Be Defined By Settlements, Not IG Guide

Executive Summary

The first PBM to settle a Justice Department investigation of its business practices could emerge with a competitive advantage in the sector, Health Strategies Consultancy Managing Director Dan Mendelson told the Schwab Washington Research Group conference May 14

You may also be interested in...



Medco Settlement Will Influence Medicare Part D Regs, Consultant Says

The regulations to implement the Medicare Part D prescription drug benefit will be influenced by the recent Medco settlement with federal and state prosecutors, Health Strategies Consultancy President Dan Mendelson told the Pharmaceutical Care Management Association's legislative conference May 5 in Washington, D.C

Medco Settlement Will Influence Medicare Part D Regs, Consultant Says

The regulations to implement the Medicare Part D prescription drug benefit will be influenced by the recent Medco settlement with federal and state prosecutors, Health Strategies Consultancy President Dan Mendelson told the Pharmaceutical Care Management Association's legislative conference May 5 in Washington, D.C

Medco Settlement Sets “Gold Standard” For PBMs Ahead Of Medicare Rx

Prosecutors expect that other pharmacy benefit management companies will adopt codes of conduct based on Medco's April 26 settlement with 20 state attorneys general and the U.S. Attorney in Philadelphia

Related Content

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel